Metraipolis › archive › dc_606b0bfaf82e

BRCA2 Reversion Mutation after Neoadjuvant Dose-Dense EC and Dose-Dense Paclitaxel in Triple-Negative Breast Cancer: A Case Report and Literature Review — Europe PMC PMID:41868534

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41868534
DOI
10.70352/scrj.cr.25-0632
License (as archived)
solo-consultazione
Archived
2026-11-04T07:43:50.405Z
SHA-256 of the archived text
f40803348ab02a57629b2f8331ce77a8a1d25349ba2a8d421939f1c9c6b385ec
Stable URL of this page
https://metraipolis.com/documento/dc_606b0bfaf82e

How to cite

BRCA2 Reversion Mutation after Neoadjuvant Dose-Dense EC and Dose-Dense Paclitaxel in Triple-Negative Breast Cancer: A Case Report and Literature Review — Europe PMC PMID:41868534 — Europe PMC (en), https://europepmc.org/article/MED/41868534 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_606b0bfaf82e (Metraipolis archive dc_606b0bfaf82e, sha256 f40803348ab02a57629b2f8331ce77a8a1d25349ba2a8d421939f1c9c6b385ec)
BibTeX
@misc{dc606b0bfaf82e,
  title = {BRCA2 Reversion Mutation after Neoadjuvant Dose-Dense EC and Dose-Dense Paclitaxel in Triple-Negative Breast Cancer: A Case Report and Literature Review — Europe PMC PMID:41868534},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41868534},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_606b0bfaf82e; sha256 f40803348ab02a57629b2f8331ce77a8a1d25349ba2a8d421939f1c9c6b385ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41868534. Agents can read the archived copy with the MCP tool read_document.